Concurrent or Sequential Chemoradiotherapy after 3-4 Cycles Induction Chemotherapy for LS-SCLC with Bulky Tumor

Jingjing Zhao; Wencheng Zhang; Puchun Er; Xi Chen; Yong Guan; Dong Qian; Jun Wang; Zhiyong Yuan; Lujun Zhao; Ping Wang; Qingsong Pang

doi:10.7150/jca.41136

Concurrent or Sequential Chemoradiotherapy after 3-4 Cycles Induction Chemotherapy for LS-SCLC with Bulky Tumor

Journal of Cancer ◽

10.7150/jca.41136 ◽

2020 ◽

Vol 11 (17) ◽

pp. 4957-4964

Author(s):

Jingjing Zhao ◽

Wencheng Zhang ◽

Puchun Er ◽

Xi Chen ◽

Yong Guan ◽

...

Keyword(s):

Induction Chemotherapy ◽

Bulky Tumor

Download Full-text

WEEKLY CISPLATIN INDUCTION CHEMOTHERAPY IN HIGH-RISK CERVICAL-CANCER PATIENTS WITH BULKY TUMOR - A PHASE-II STUDY

International Journal of Oncology ◽

10.3892/ijo.6.5.1033 ◽

1995 ◽

Author(s):

D KATSAROS ◽

P ZOLA ◽

G SINISTRERO ◽

T BERGAMINO ◽

A RUMORE ◽

...

Keyword(s):

Cervical Cancer ◽

High Risk ◽

Cancer Patients ◽

Induction Chemotherapy ◽

Phase Ii ◽

Phase Ii Study ◽

Bulky Tumor ◽

Weekly Cisplatin

Download Full-text

Factors associated with long term freedom from recurrence after induction chemotherapy and extrapleural pneumonectomy in mesothelioma patient

Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie ◽

10.1055/s-0036-1587519 ◽

2016 ◽

Vol 141 (S 01) ◽

Author(s):

I Opitz ◽

M Friess ◽

M Meerang ◽

M Kirschner ◽

K Bérard ◽

...

Keyword(s):

Induction Chemotherapy ◽

Extrapleural Pneumonectomy ◽

Factors Associated

Download Full-text

How to improve quality of life in patients with acute leukemia and comorbid ischemic heart disease treated with anthracycline-based induction chemotherapy

Experimental Oncology ◽

10.32471/exp-oncology.2312-8852.vol-41-no-4.13906 ◽

2019 ◽

Vol 41 (4) ◽

Author(s):

I. Skrypnyk ◽

◽

G. Maslova ◽

T.* Lymanets ◽

I. Gusachenko ◽

...

Keyword(s):

Quality Of Life ◽

Heart Disease ◽

Acute Leukemia ◽

Ischemic Heart Disease ◽

Induction Chemotherapy ◽

Ischemic Heart ◽

Improve Quality

Download Full-text

Faculty Opinions recommendation of Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1123209.580347 ◽

2008 ◽

Author(s):

Ricardo Hitt

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Neck Cancer ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Trial ◽

Advanced Head ◽

Radiotherapy Dose ◽

Dose Levels

Download Full-text

Faculty Opinions recommendation of Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3359960.3049058 ◽

2010 ◽

Author(s):

David Potter

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Locally Advanced ◽

Prospective Trial ◽

Advanced Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Combination of taxanes, cisplatin and fluorouracil as induction chemotherapy for locally advanced head and neck cancer: a meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969302.793470084 ◽

2013 ◽

Author(s):

Iain Nixon

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Induction Chemotherapy ◽

Neck Cancer ◽

Meta Analysis ◽

Locally Advanced ◽

Advanced Head

Download Full-text

Faculty Opinions recommendation of Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726178132.793548556 ◽

2018 ◽

Author(s):

Stephen Nimer

Keyword(s):

Acute Myeloid Leukemia ◽

Induction Chemotherapy ◽

Myeloid Leukemia ◽

Gemtuzumab Ozogamicin ◽

Acute Myeloid

Download Full-text

Faculty Opinions recommendation of Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732647853.793552975 ◽

2018 ◽

Cited By ~ 1

Author(s):

Jason Chan

Keyword(s):

Nasopharyngeal Carcinoma ◽

Induction Chemotherapy ◽

Randomized Trials ◽

Concurrent Chemoradiotherapy ◽

Individual Patient Data ◽

Pooled Analysis ◽

Patient Data

Download Full-text

Surgical Resection for Residual N2 Disease After Induction Chemotherapy

The Annals of Thoracic Surgery ◽

10.1016/j.athoracsur.2004.10.057 ◽

2005 ◽

Vol 79 (5) ◽

pp. 1686-1690 ◽

Cited By ~ 21

Author(s):

Jeffrey L. Port ◽

Robert J. Korst ◽

Paul C. Lee ◽

Matthew A. Levin ◽

David E. Becker ◽

...

Keyword(s):

Surgical Resection ◽

Induction Chemotherapy ◽

N2 Disease

Download Full-text

Induction Chemotherapy Followed by Concomitant Chemoradiotherapy for Non‐Small Cell Lung Cancer

The Oncologist ◽

10.1634/theoncologist.6-suppl_1-25 ◽

2001 ◽

Vol 6 (S1) ◽

pp. 25-27 ◽

Cited By ~ 9

Author(s):

Everett E. Vokes

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Concomitant Chemoradiotherapy

Download Full-text